Sichuan Biokin Pharmaceutical Gets FDA Approval for BL-B01D1 Clinical Study
Sichuan Biokin Pharmaceutical Co., Ltd (SHA: 688506), a China-based pharmaceutical company, has announced that it...
Sichuan Biokin Pharmaceutical Co., Ltd (SHA: 688506), a China-based pharmaceutical company, has announced that it...
The Center for Drug Evaluation (CDE) website in China has indicated that RareStone Group, a...
China-based Joincare Pharmaceutical Group Industry Co., Ltd (SHA: 600380) has announced the initiation of a...
China-based Bio-heart Biological Technology Co., Ltd. (HKG: 2185) and its holding subsidiary Angiocare have announced...
Sisram Medical Ltd (HKG: 1696), an Israel-based company and part of the Fosun Pharmaceutical Group...
Beijing Sun-Novo Pharmaceutical Research Co., Ltd (SHA: 688621) has announced a significant licensing agreement with...
Guangdong Zhongsheng Pharmaceutical Co., Ltd (SHE: 002317), a China-based pharmaceutical company, has announced preliminary top-line...
The National Medical Products Administration (NMPA) has issued a marketing approval for China-based Hansoh Pharmaceutical...
China-based Sinocelltech Group Ltd (SHA: 688520) has announced that it has received marketing approval from...
Cornerstone Robotics, a leading surgical robot developer based in Shenzhen, has reportedly raised RMB 800...
China-based Huadong Medicine Co., Ltd (SHE: 000963) has announced that it has received approval from...
The National Healthcare Security Administration (NHSA) has released the “Work Plan for the National Reimbursement...
China-based Sinocelltech Group Ltd (SHA: 688520) has announced receiving approval from the National Medical Products...
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a leading pharmaceutical company based in China, has...
China-based Jacobio Pharma (HKG: 1167) has announced clinical results for its novel KRAS G12C inhibitor,...
Harbour BioMed (HKG: 2142), a biotech company with operations in the United States, the Netherlands,...
China-based Hansoh Pharmaceutical Group Co., Ltd (HKG: 3692) has announced receiving approval from the National...
Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252) has announced that its in-house developed Dragonfly...
Germany-based Merck KGaA (NYSE: MRK) has announced plans to expand production capacity for highly-purified reagents...
Shanghai Pharmaceuticals Holding Co., Ltd’s (SHA: 601607, HKG: 2607) subsidiary, MediTrust Health, which specializes in...